Discovery of immune group
in Uganda raises Aids vaccine hopes
Rory Carroll in Entebbe and
Sarah Boseley, health editor
Tuesday May 20, 2003 The Guardian
Scientists believe an effective Aids vaccine may be a step closer after studying
an unexpected response to the HIV virus in individuals in Uganda who appear
immune.
Just over two dozen people near Lake Victoria have been found to remain
uninfected even though they have unprotected sex with HIV-positive partners, a
phenomenon termed "discordant couples".
Researchers found that the immune systems of the 28 resistant individuals
behaved in surprising ways which, it is hoped, will point the way to a vaccine
within 10 years.
Some of the resistant individuals had a lower measured immune response than
infected partners but their immune systems attacked the virus more effectively,
keeping them HIV negative. The finding suggests that what matters is quality,
not quantity, of immune response.
The Ugandan results suggest resistant individuals are a more widespread and
significant phenomenon than first realised, researchers said.
They expect to cause a stir by calling on the scientific community to focus
half of vaccine research on resistant individuals, a dramatic scaling up of what
has been until now a minority interest.
The research in Entebbe takes forward the findings from studies of a small
group of commercial sex workers in Kenya. The Nairobi women's apparent immunity
triggered a line of research which has led to the most promising vaccine now in
trials, a joint enterprise between the universities of Oxford and Nairobi.
The findings come from the Uganda Virus Research Institute, which is backed
by the International Aids Vaccine Initiative (IAVI), a not-for-profit
organisation set up to channel funds into promising projects.
The Entebbe-based institute started phase one trials in February of the
promising DNA-MVA vaccine designed by Pro fessor Andrew McMichael at Oxford
University in collaboration with scientists in Nairobi. Specifically designed to
combat the A strain of the HIV virus prevalent in east Africa, phase two trials
are under way in the UK and Kenya.
The Ugandan discordant couple research is expected to be published this year.
Scientists are most excited by the minority of resistant partners who possess
T-cells which kill cells infected with HIV in a narrow, targeted attack, unlike
their partners whose immune systems launch wider, bigger - and unsuccessful -
attacks.
DISCLAIMER: All
information, data, and material contained, presented, or provided here is for
general information purposes only and is not to be construed as reflecting the
knowledge or opinions of the publisher, and is not to be construed or intended
as providing medical or legal advice. The decision whether or not to vaccinate
is an important and complex issue and should be made by you, and you alone, in
consultation with your health care provider.
"A foolish faith in authority is the worst enemy of truth."
-- Albert Einstein, letter to a friend, 1901
"I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education."
-- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820
"What's the point of vaccination if it doesn't protect you from the unvaccinated?"
-- Sandy Gottstein
"Who gets to decide what the greater good is and how many will be sacrificed to it?"